Application of Ferulic Acid for Alzheimer’s Disease: Combination of Text Mining and Experimental Validation

Alzheimer’s disease (AD) is an increasing concern in human health. Despite significant research, highly effective drugs to treat AD are lacking. The present study describes the text mining process to identify drug candidates from a traditional Chinese medicine (TCM) database, along with associated protein target mechanisms. We carried out text mining to identify literatures that referenced both AD and TCM and focused on identifying compounds and protein targets of interest. After targeting one potential TCM candidate, corresponding protein-protein interaction (PPI) networks were assembled in STRING to decipher the most possible mechanism of action. This was followed by validation using Western blot and co-immunoprecipitation in an AD cell model. The text mining strategy using a vast amount of AD-related literature and the TCM database identified curcumin, whose major component was ferulic acid (FA). This was used as a key candidate compound for further study. Using the top calculated interaction score in STRING, BACE1 and MMP2 were implicated in the activity of FA in AD. Exposure of SHSY5Y-APP cells to FA resulted in the decrease in expression levels of BACE-1 and APP, while the expression of MMP-2 and MMP-9 increased in a dose-dependent manner. This suggests that FA induced BACE1 and MMP2 pathways maybe novel potential mechanisms involved in AD. The text mining of literature and TCM database related to AD suggested FA as a promising TCM ingredient for the treatment of AD. Potential mechanisms interconnected and integrated with Aβ aggregation inhibition and extracellular matrix remodeling underlying the activity of FA were identified using in vitro studies.

[1]  S. Pimplikar Multi-omics and Alzheimer's disease: a slower but surer path to an efficacious therapy? , 2017, American journal of physiology. Cell physiology.

[2]  Shu-Hua Yang,et al.  Ferulic acid promoting apoptosis in human osteosarcoma cell lines , 2017, Pakistan journal of medical sciences.

[3]  S. Brunak,et al.  A scored human protein–protein interaction network to catalyze genomic interpretation , 2017, Nature Methods.

[4]  S. Adisakwattana,et al.  Ferulic acid prevents methylglyoxal-induced protein glycation, DNA damage, and apoptosis in pancreatic β-cells , 2016, Journal of Physiology and Biochemistry.

[5]  Gerold Schmitt-Ulms,et al.  Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining , 2016, PloS one.

[6]  Jaehoon Yu,et al.  Protective effects of a dimeric derivative of ferulic acid in animal models of Alzheimer's disease. , 2016, European journal of pharmacology.

[7]  O. Andreassen,et al.  Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease. , 2016, JAMA neurology.

[8]  H. Shin,et al.  Cognitive-Enhancing Herbal Formulae in Korean Medicine: Identification of Candidates by Text Mining and Literature Review. , 2016, Journal of alternative and complementary medicine.

[9]  L. Schneider,et al.  Defeating Alzheimer's disease and other dementias: a priority for European science and society , 2016, The Lancet Neurology.

[10]  B. N. Sinha,et al.  Monoamine Oxidase Inhibitory Activity of Ferulic Acid Amides: Curcumin‐Based Design and Synthesis , 2016, Archiv der Pharmazie.

[11]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[12]  Jeffrey R. Wang,et al.  Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles , 2015, Cell & Bioscience.

[13]  C. Xue,et al.  The systematic assessment of traditional evidence from the premodern Chinese medical literature: a text-mining approach. , 2014, Journal of alternative and complementary medicine.

[14]  J. Quillfeldt,et al.  Amnesia of inhibitory avoidance by scopolamine is overcome by previous open-field exposure , 2014, Learning & memory.

[15]  Huajun Chen,et al.  Modern bioinformatics meets traditional Chinese medicine , 2014, Briefings Bioinform..

[16]  Tzu-Chi Chen,et al.  Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. , 2014, Journal of proteome research.

[17]  Sorel Muresan,et al.  Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database , 2013, Molecular informatics.

[18]  D. Selkoe,et al.  The therapeutics of Alzheimer's disease: Where we stand and where we are heading , 2013, Annals of neurology.

[19]  Min Song,et al.  Entitymetrics: Measuring the Impact of Entities , 2013, PloS one.

[20]  You Li,et al.  Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils. , 2013, Journal of Alzheimer's disease : JAD.

[21]  H. Soininen,et al.  Clinical symptoms and symptom signatures of Alzheimer's disease subgroups. , 2013, Journal of Alzheimer's disease : JAD.

[22]  I. Grundke‐Iqbal,et al.  Opportunities and challenges in developing Alzheimer disease therapeutics , 2011, Acta Neuropathologica.

[23]  R. Chang,et al.  Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia , 2011, Chinese medicine.

[24]  J. Qiu,et al.  Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA , 2011, PloS one.

[25]  Tao Huang,et al.  Competitive Binding to Cuprous Ions of Protein and BCA in the Bicinchoninic Acid Protein Assay , 2010, The open biomedical engineering journal.

[26]  Role of structural bioinformatics and traditional Chinese medicine databases in pharmacogenomics. , 2009, Pharmacogenomics.

[27]  Steve Iliffe,et al.  Alzheimer’s disease , 2009, BMJ : British Medical Journal.

[28]  M. Fenner Duplication: stop favouring applicant with longest list , 2008, Nature.

[29]  A. Alavi,et al.  Opportunities and Challenges , 1998, In Vitro Diagnostic Industry in China.

[30]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[31]  Wanda Pratt,et al.  Using statistical and knowledge-based approaches for literature-based discovery , 2006, J. Biomed. Informatics.

[32]  M. Peitsch,et al.  The application of systems biology to drug discovery. , 2006, Current opinion in chemical biology.

[33]  A. Singh,et al.  Multiple biological activities of curcumin: a short review. , 2006, Life sciences.

[34]  R. Bullock,et al.  The Needs of the Caregiver in the Long-Term Treatment of Alzheimer Disease , 2004, Alzheimer disease and associated disorders.

[35]  Marc Weeber,et al.  Case Report: Generating Hypotheses by Discovering Implicit Associations in the Literature: A Case Report of a Search for New Potential Therapeutic Uses for Thalidomide , 2003, J. Am. Medical Informatics Assoc..

[36]  K. Miyazaki,et al.  Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity* , 2003, The Journal of Biological Chemistry.

[37]  D. Swanson,et al.  Linking estrogen to Alzheimer's disease , 1996, Neurology.